Skip to main content
SpringerLink
Log in

Current status of cancer imaging with radiolabeled antibodies

  • Guest Editorial
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Summary

This editorial reviews the development, current status, and future prospects of cancer imaging with radioactive antibodies, termed radioimmunodetection (RAID). There has been a slow and steady development of this field for more than 35 years, with more recent activity and progress resulting from the identification of human tumor-associated antibodies and suitable human tumor xenograft models, the demonstration that circulating antigens do not prevent radioantibody localization in tumor, the development of computer-assisted and biological methods for reducing non-target background radioactivity, and the advent of hybridoma-produced monoclonal antibodies. At the present time, tumor sites in the range of 1.5 to 2.0 cm can be imaged, with the best resolution of 0.4–0.5 cm being reported with new chelates of 99mTc. A number of factors, including character of the radioantibody and its bioavailability, the tumor antigen site and bioavailability, the character of the radiolabel, and the target tumor's size, location and vascularization, contribute to the sensitivity, specificity, accuracy, and resolution of the method. Already at this early stage of development, RAID has been shown to have, in certain tumor types and with particular antibody and imaging systems, an accuracy of tumor site detection of over 90%, with the disclosure of occult lesions. Carefully designed prospective trials are needed to fully assess the role of this new modality in the management of cancer patients, particularly in early detection of primary and recurrent tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Selected bibliography

  • Ballou B, Levine G, Hakala RR, Solter D (1979) Tumor location detected with radioactivity labeled monoclonal antibody and external scintigraphy. Science 206:844–847

    Google Scholar 

  • Begent RHJ (1985) Recent advances in tumor imaging, use of radiolabelled antitumour antibodies. Ciochim Biophys Acta 780:151–166

    Google Scholar 

  • Belitsky P, Ghose T, Aquino J, Norwell ST, Blau AH (1978) Radionoscintigraphy with I-123, Tc-99m and In-111-labeled F(ab′)2 fragments of monoclonal antibodies to human high molecular

  • Buraggi GL, Callegaro L, Turrin A, Cascinelli N, Attili A, Emanuelli H, Gasparini M, Deleide G, Plassio G, Dovis M, Mariani G, Natali PG, Scassellati GA, Rosa U, Ferrone S (1984) Immunoscintigraphy with I-123, Tc-99m and In-111-labeled F(ab′)2 fragments of monoclonal antibodies to humam hig molecular weight melanoma-associated antigen (HMW-MAA). J Nucl Med Allied Sci 28:283–295

    Google Scholar 

  • DeLand F, Kim E, Corgan R, Casper S, Primus FJ, Spremulli E, Estes N, Goldenberg D (1979) Axillary lymphoscintigraphy in radioimmunodetection of carcinoembryonic antigen in breast cancer. J Nucl Med 20:1243–1250

    Google Scholar 

  • DeLand FH, Goldenberg DM (1983) Diagnosis and treatment of neoplasms with radionuclide-labelled antibodies. Sem Nucl Med 15:2–11

    Google Scholar 

  • DeLand FH, Goldenberg DM (1986) Radiolabeled antibodies: radiochemistry and clinical applications. In: Freeman LM (ed) Freeman and Johnson's clinical radionuclide imaging. Grune & Stratton, Orlando, Florida, pp 1915–1992

    Google Scholar 

  • Dewey WC, Bale WF, Rose RG, Marrack D (1963) Localization of antifibrin antibodies in human tumors. Acta Unio Int Contra Cancer 19:185–186

    Google Scholar 

  • Epenetos A, Britton KE, Mather S, Shepherd J, Granowska M, Taylor-Papadimitriou J, Nimmon C, Durbin H, Hawkins L, Malpas JS, Bodmer F (1982) Targeting of I-123 tumor-associated antibodies to overian, breast and gastrointestinal tumors. Lancet II:999–1005

    Google Scholar 

  • Fairweather D, Bradwell A, Dykes P, Vaughan A, Watson-James S, Chandler S (1983) Improved tumor localization using In-111 labeled antibodies. Brit Med J 287:167–170

    Google Scholar 

  • Gaffar SA, Pant KD, Shochat D, Bennett SJ, Goldenberg DM (1981) Experimental studies of tumor radioimmunodetection using antibody mixtures against carcinoembryonic antigen (CEA) and colon-specific antigen-p (CSAp). Int J Cancer 27:101–105

    Google Scholar 

  • Goldenberg DM, Preston DF, Primus FJ, Hansen HJ (1974) Photoscan localization of GW-39 tumors in hamster using radiolabeled anticarcinoembryonic antigen immunoglobulin G. Cancer Res 34:1–9

    Google Scholar 

  • Goldenberg DM, DeLand F, Kim E, Bennett S, Primus FJ, van Nagell JR Jr, Estes N, DeSimone P, Rayburn P (1978) Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by photoscanning. NEJM 298:1384–1388

    Google Scholar 

  • Goldenberg DM, Kim EE, DeLand F, Spremulli E, Nelson MO, Gockerman JP, Primus FJ Corgan R, Alpert E (1980) Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein. Cancer 45:4500–4505

    Google Scholar 

  • Goldenberg DM, Kim EE, DeLand F, van Nagell JR Jr, Javadpour, N (1980) Clinical radioimmunodetection of cancer with radioactive antibodies to human chorionic gonadotropin. Science 208:1284–1286

    Google Scholar 

  • Goldenberg DM, DeLand FH (1983) History and status of tumor imaging with radiolabeled antibodies. J Biol Response Modif 1: 121–136

    Google Scholar 

  • Keenan AM, Harbert JL, Larson SM (1985) Monoclonal antibodies in nuclear medicine. J Nucl Med 26:531–537

    Google Scholar 

  • Krejcarek GE, Tucker KL (1977) Covalent attachment of chelating group to macromolecules. Biochem Biophys Res Commun 77:581–585

    Google Scholar 

  • Mach JP, Carrel S, Merenda C, Sordat B, Cerottini JC (1974) In vivo localization of radiolabeled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature 248:704–706

    Google Scholar 

  • Mach JP, Forni M, Ritschard J, Buchegger F, Carrel S, Widgren S, Douath A, Alberto P (1980) Use and limitations of radiolabeled anti-CEA antibodies and their fragments for photoscanning detection of human colorectal carcinomas. Oncodevel Biol Med 1:49–69

    Google Scholar 

  • Mach JP, Buchegger F, Forni M, Ritschard J, Berche C, Lumbroso JD, Schreyer M, Girardet C, Accolla RS, Carrel S (1981) Use of radiolabeled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy. Immunol Today 2:239–249

    Google Scholar 

  • Mahaley MS Jr, Day ED (1965) Immunological studies of human gliomas. J Neurosurg 23:363–370

    Google Scholar 

  • Pettit WA, DeLand FH, Bennett SJ, Goldenberg DM (1980) Radiolabeling of affinity-purified goat anti-carcinoembryonic antigen immunoglobulin G with technetium-99m. Cancer Res 40:3043–3045

    Google Scholar 

  • Pressman D, Keighly G (1948) The zone of activity of antibodies as determined by the use of radioactive tracers: The zone of activity of nephrotoxic anti-kidney serum. J Immunol 59:141–146

    Google Scholar 

  • Pressman D, Korngold L (1952) Experimental hypersensitivity. Science 116:483

    Google Scholar 

  • Pressman D, Day ED, Blau M (1957) The use of paired labeling in the determination of tumor-localizing antibodies. Cancer Res 17:845–850

    Google Scholar 

  • Primus FJ, Wang RH, Goldenberg DM, Hansen HJ (1973) Localization of human GW-39 tumors in hamsters by radiolabeled heterospecific antibody to carcinoembryonic antigen. Cancer Res 33:2977–2982

    Google Scholar 

  • Primus FJ, MacDonald R, Goldenberg DM, Hansen HJ (1977) Tumor detection and localization with purified antibodies to carcinoembryonic antigen. Cancer Res 37:1544–1547

    Google Scholar 

  • Primus FJ, Bennett SJ, Kim EE, DeLand FH, Zahn MC, Goldenberg DM (1980) Circulating immune complexes in cancer patients receiving goat radiolocalizing antibodies to carcinoembryonic antigen. Cancer Res 40:497–501

    Google Scholar 

  • Quinones J, Mizejewski G, Beierwalter WH (1971) Choriocarcinoma scanning using radiolabeled antibody to chorionic gonadotropin. J Nucl Med 12:69–75

    Google Scholar 

  • Scheinberg DA, Strand M, Gansow O (1982) Tumor imaging with radiometal chelate conjugated monoclonal antibodies. Science 215:1511–1513

    Google Scholar 

  • Sharkey RM, Priimus FJ, Goldenberg DM (1984) Second anibody clearance of radiolabeled antibody in cancer radioimmunodetection. Proc Natl Acad Sci USA 81:2843–2846

    Google Scholar 

  • Siccardi AG, Buraggi GL, Callegaro L, Mariani G, Natali PG, Abbati A, Bestagno M, Caputo V, Mansi L, Masi R, Paganelli G, Riva P, Salvatore M, Sanguineti M, Troncone L, Turco GL, Scassellati GA, Ferrone S (1986) Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma. Cancer Res 46:4817–4822

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Molecular Medicine and Immunology, University of Medicine and Dentistry of New Jersey, 07103, Newark, New Jersey, USA

    David M. Goldenberg

Authors
  1. David M. Goldenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Dedicated to Professor E. Grundmann, Director of the Pathology Institute, University of Munster, on the occasion of his 65th birthday, and in gratitude for his encouragement and support of my research for over 20 years

The “Journal of Cancer Research and Clinical Oncology” publishes in loose succession “Editorial” and “Guest Editorials” on current and/or controversial problems in experimental and clinical oncology. These contributions represent exclusively the personal opinion of the author. The Editors

The author's studies in this area are being supported by OIA grant CA-39841 from the National Cancer Institute, NIH

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goldenberg, D.M. Current status of cancer imaging with radiolabeled antibodies. J Cancer Res Clin Oncol 113, 203–208 (1987). https://doi.org/10.1007/BF00396374

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00396374

Key words

Search

Navigation